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ABSTRACT 
Purpose: Urinary tract infection is one of the most common infections in childhood. Because of the long term sequelae, 
differentiation of pyelonephritis from cystitis is important. The aim of this study is to determine the value of biomarkers 
such as C-reactive protein and procalcitonin and whether preferred to predict pyelonephritis in children without 99mTc-
Dimercaptosuccinic Acid scan. 
Material and Methods: Fifty children aged 3 months to 16 years with a first urinary tract infection were included in this 
retrospective observational study. The medians, sensitivity, specificity, and cut-off values of serum C - reactive protein 
and procalcitonin to predict pyelonephritis were determined. 
Results: Thirty-two (64%) patients were diagnosed with pyelonephritis and 18 (36%) were diagnosed with cystitis. The 
cut-off value for C - reactive protein was 34 mg/L to predict pyelonephritis, with 69% sensitivity and 61% specificity. The 
cut-off value for procalcitonin was 0.23 ng/mL to predict pyehlonephritis, with 69% sensitivity and 66% specificity. In 
combination, these biomarkers were 63% sensitive and 78% specific to predict pyelonephritis. 
Conclusion: Using a combination of procalcitonin and C-Reactive Protein is preferred to predict pyelonephritis in 
children, instead of the 99mTc-Dimercaptosuccinic Acid scan. Because of its disadvantages, the 99mTc-
Dimercaptosuccinic Acid scan should be avoided in children.  
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ÖZET 
Amaç: İdrar yolu enfeksiyonu, çocukluk çağının en sık görülen enfeksiyonlarından biridir. Piyelonefritin uzun dönemde 
görülen sekelleri nedeniyle sistitten ayırımı önemlidir. Bu çalışmanın amacı,  çocuklarda 99mTc-Dimerkaptosüksinik 
Asid ile sintigrafik görüntüleme yapılmaksızın piyelonefrit ayırımını yapmakta prokalsitonin ve C-Reaktif Protein gibi 
belirteçlerin tanısal değerini saptamak, 99mTc-Dimerkaptosüksinik Asid ile sintigrafik görüntüleme yapılacak hastalar 
konusunda yol gösterici olup olmayacağını belirlemektir. 
Materyal ve Metod: Bu çalışmaya, 3 ay ile 16 yaş arasında, ilk kez idrar yolu enfeksiyonu geçiren 50 çocuk dahil 
edilmiştir. Retrospektif gözleme dayalı bir çalışmadır. Piyelonefrit tanısı için serum C-Reaktif Protein ve prokalsitonin 
düzeylerinin ortanca değeri, duyarlılık, özgüllük ve cut-off değerleri saptandı. 
Bulgular: Hastaların 32’si (%64) piyelonefrit tanısı alırken, 18 (%36) hasta sistit tanısı aldı. Piyelonefrit tanısı için C-
Reaktif Protein cut-off değeri %69 duyarlılık ve %61 özgüllük ile 34 mg/L iken, prokalsitonin için bu değer %69 duyarlılık 
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ve %66 özgüllük ile 0,23 ng/mL saptandı. Her iki belirteçin birlikte kullanılması ise %63 duyarlılık ve %78 özgüllük ile 
piyelonefrit tanısını destekledi.  
Sonuç: Çocuklarda piyelonefrit tanısını koymakta serum prokalsitonin ve C-Reaktif Proteinin birlikte değerlendirilmesi, 
99mTc-Dimerkaptosüksinik Asid ile sintigrafik görüntüleme yapılacak hastalarda yol gösterici olabilir. Böylece çocuklar 
99mTc-Dimerkaptosüksinik Asid ile sintigrafik görüntülemenin dezavantajlarından uzak tutulabilir. 
Anahtar Kelimeler: Prokalsitonin, Piyelonefrit, C-Reaktif Protein 
INTRODUCTION 
 Urinary tract infections (UTIs) are common in 
childhood. Symptoms may vary with age and 
include vomiting, growth retardation, irritability, 
dysuria, diarrhea, constipation, urgency, and 
abdominal pain. Fever may be the only symptom, 
especially in infants
1,2
.
 
 The differentiation between upper and lower 
UTIs is important because of long term sequelae. 
When UTI is limited to the bladder, it is known as 
cystitis; if it spreads to the kidneys it may cause 
pyelonephritis. Pyelonephritis, unlike cystitis, 
increases the risk of renal scarring, which may 
eventually lead to hypertension, proteinuria, and 
chronic renal disease in the long term period
1,3
. In 
Turkish children, vesicoureteral reflux and related 
urological problems initially presenting as UTIs, 
and are the predominant underlying causes of 
chronic kidney disease
4
. 
 The diagnosis of acute pyelonephritis is 
generally based on symptoms such as fever, flank 
pain associated with pyuria, and a positive urine 
culture
5
. However, the gold standard for diagnosis 
is 
99m
Tc-dimercaptosuccinic acid (DMSA) scan
6
. 
The disadvantages of DMSA include high cost, 
radiation exposure, and the fact that it is not 
available in all centers
7
. 
 C-reactive protein (CRP) is also accepted as 
an alternative confirmation of the presence of 
pyelonephritis. High CRP levels are an indicator of 
tissue injury or inflammation
6
. Another indicator of 
infection with systemic inflammation is 
procalcitonin (PCT), a propeptide of calcitonin, 
described in 1993
8
. Several studies have 
demonstrated the importance of PCT and CRP, 
and each one is more valuable to determine the 
level of UTI. 
 
 
 The primary aim of this study was to 
determine the diagnostic value of PCT and CRP as 
markers of pyelonephritis. 
MATERIAL and METHODS 
 We have retrospectively reviewed the medical 
records of children admitted to Department of 
Pediatric Nephrology of Baskent University, 
Faculty of Medicine, Adana Teaching and Medical 
Research Center, in southern Turkey, during the 
past 6 months. We enrolled 50 children aged 3 
months to 16 years old with first UTI. Clinical 
findings such as fever, feeding problems, irritability, 
vomiting, abdominal pain, malodorous urine, 
dysuria, pollacuria, urinary incontinence, 
hematuria, constipation, and flank pain; and 
laboratory features including urinalysis, urine 
culture, white blood cell count, CRP, PCT and 
DMSA scan were recorded. Renal and bladder 
functions were normal. Urine samples for urinalysis 
were obtained by the midstream method in toilet-
trained children and by a urine bag in infants and 
small children. If culture was required, bladder 
catheterization or suprapubic aspiration was 
performed in infants. UTI was defined by the 
presence of  ≥100,000 colonies per milliliter of a 
single bacterial species on a specimen obtained by 
the midstream method; ≥50,000 colonies for 
catheterization and ≥1000 colonies was definitive 
of infection in suprapubic aspiration. PCT was 
determined by the electrochemieluminescence 
immunoassay method. A PCT of greater than 0.05 
ng/ml was considered abnormal. CRP was 
determined by the nepholometric method, 
according to the manufacturer's instructions. A 
CRP of greater than 6 mg/L was considered 
abnormal. In our study, patients with a potential of 
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raising the CRP and PRC values nonspecifically, 
patients with surgical, traumatic or any other kind 
of infection were excluded. The DMSA scan was 
performed on every child with a positive urine 
culture within 7 days of admission. Patients were 
planarily screened with "GE medical systems 
infinia israel" and "SIEMENS symbia true point 
SPECT CT USA " devices. Four hours after the 
patients were given 3 mCi (111 mBq) 99mTc-
DMSA intravenously, patients were screened in 
anterior, posterior, right posterior oblique, and left 
posterior oblique positions. Pyelonephritis was 
defined as focal or diffuse areas of decreased or 
absent DMSA uptake.  
 Statistical analysis was performed using the 
SPSS software version 17.0. For each continuous 
variable, normality was checked by the 
Kolmogorov Smirnov and Shapiro-Wilk tests and 
by histograms. Comparisons between groups were 
performed using the Mann-Whitney U test for data 
not normally distributed. Receiver operating 
characteristic curves (ROC curves), areas under 
the curve (AUC), sensitivity, and specificity were 
calculated. A p-value of less than 0.05 was 
considered as statistically significant. Cut off 
values for CRP and PCT were determined by ROC 
analysis by taking the highest common values of 
sensitivity and specificity values. 
RESULTS 
 Fifty children were diagnosed with UTI. Mean 
age was 56 months old (range 3 months to 16 
years). Eighty four percent of cases were female. 
There were 31 (62%) toilet trained children in the 
cohort. The most frequent symptoms were fever 
(72%), abdominal pain (32%), vomiting (30%), 
irritability (22%), incontinence (20%), dysuria 
(16%), flank pain (16%), and feeding problems 
(16%). The most commonly isolated 
microorganism from urine samples was 
Escherichia coli (82%). Other microorganisms 
were Klebsiella (6%), Proteus (6%), and 
Enterococcus fecalis (6%).  
 The results of the DMSA scan for 32 (64%) 
children revealed pyelonephritis. Eighteen (36%) 
were diagnosed as cystitis with a normal DMSA 
scan. Four boys (4/8; 50%) and 28 girls (28/42; 
67%) were diagnosed with pyelonephritis. The 
median age of children with pyelonephritis and 
cystitis were 74 and 19 months, respectively. 
Comparison of age and gender of children with 
cystitis and pyelonephritis showed no statistically 
significant difference (p=0.069 and p=0.436, 
respectively). Among those with pyelonephritis, 
69% (22/32) of them were toilet-trained; while 50% 
(9/18) with cystitis were toilet-trained (p=0.233). No 
statistically significant difference was detected 
between groups in case of fever existence (≥38ºC 
axillary) (p=0.325; Table 1). 
 The median CRP of children with 
pyelonephritis and cystitis were 70.5 mg/L (3-303) 
and 9.8 mg/L (3-144) respectively. The median 
PCT of children with pyelonephritis and cystitis 
were 0.64 ng/ml (0.03-21.1), and 0.1 ng/ml (0.02-
14.4) respectively. The median CRP and PCT 
values were found to be statistically significant 
between groups (p=0.016 and p=0.030, 
respectively) (Fig. 1) 
 The cut-off value for CRP was 34 mg/L to 
predict pyelonephritis, with 69% sensitivity and 
61% specificity (AUC=0.71; Figure-2a); while the 
cut-off value for PCT was 0.23 ng/ml to predict 
pyelonephritis, with 69% sensitivity and 66% 
specificity (AUC=0.69; Fig. 2b). When CRP and 
PCT were combined, the sensitivity was 63% and 
the specifity was 78% to predict pyelonephritis at 
their cut-off values. 
 In our study, positive predictive value is 
75.9% (60.3-91.4, 95% CI) for CRP over 34 mg/L 
and the negative predictive value is 52.4%  (31.0-
73.7, 95% CI). The positive predictive value for 
PCT over 0.23 ng/ml was found as 78.6% (63.4-
93.8, 95% CI) and the negative predictive value as 
54.5% (33.7-75.4). In the situation of CRP and 
PCT together being stated as high, then the 
positive predictive value was found as 83.3% 
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(68.4-98.2, 95% CI) and the negative predictive 
value was 53.8% (34.7-73, 95% CI). 
 
 
Table 1. Symptoms of the patients with pyelonephritis and cystitis in our study 
Symptoms Pyelonephritis (n=32) Cystitis  (n=18) p value 
Fever 
25 (78%) 11 (61%) > 0.05 
Abdominal pain 
12 (38%) 4 (22%) > 0.05 
Vomiting 
10 (31%) 5 (28%) > 0.05 
Irritability 
7 (22%) 4 (22%) > 0.05 
Incontinence 
9 (28%) 1 (6%) > 0.05 
Dysuria 
5 (16%) 3 (17%) > 0.05 
Flank pain 
5 (16%) 3 (17%) > 0.05 
Feeding problems 
4 (13%) 4 (22%) > 0.05 
Pollacuria  
3 (9%) 0 (0%) > 0.05 
Bad odor of urine 
0 (0%) 2 (11%) > 0.05 
Constipation  
0 (0%) 2 (11%) > 0.05 
Table 2. Sensitivity and specificity of C-reactive protein to predict pyelonephritis 
 Sensitivity Specificity Cut-off values 
Benador et al. (1998) [12]
 
100% 26% 10 mg/L 
Biggi et al. (2001) [11]
 
64% 68% 87.5 mg/dl 
Gürgöze et al. (2005) [13] 94% 58% 20 mg/L 
Tuerlinckx et al. (2005) [18]
 
94% 39% 34 mg/L 
Bigot et al. (2005) [19]
 
94% 30% 20 mg/L 
Güven et al. (2005) [17]
 
67% 67% 2 mg/dl 
Karavanaki et al. (2007) [20]
 
73% 70% 50mg/L 
Kotoula et al. (2009) [21]
 
81% 90% 3.5 mg/dl 
Ayazi et al. (2009) [16]
 
96 % 4% 10 mg/L 
Nikfar et al. (2010) [15]
 
80% 65% 20 mg/L 
In current study 69% 61% 34 mg/L 
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Table 3. Sensitivity and specificity of procalcitonin to predict pyelonephritis 
 Sensitivity Specificity  Cut-off value 
Benador et al. (1998) [12]
 
70% 83% 0.6 µg/L 
Gervaix et al. (2001) [22] 74% 85% 0.5 ng/ml 
Prat et al. (2003) [23]   92% 62% 1 ng/ml 
Gürgöze et al. (2005) [13]
 
58% 76% 0.5 ng/ml 
Tuerlinckx et al. (2005) [18]
 
68% 23% 0.5 ng/ml 
Güven et al. (2005) [17]
 
77% 45% 1 ng/ml 
Bigot et al. (2005) [19]
 
100% 87% 0.5 ng/ml 
Karavanaki et al. (2007) [20]
 
94% 88% 0.8 µg/L 
Ayazi et al. (2009) [16]
 
71 % 46% 0.5 ng/ml 
Kotoula et al. (2009) [21]   89%   97% 0.85 ng/ml 
Nikfar et al. (2010) [15]
 
77% 89% 0.5 ng/ml 
In current study 69% 66% 0.23 ng/ml 
 
 
Figure 1. The median serum C-reactive protein (1a) and procalcitonin (1b) concentrations of the patients with urinary 
tract infection (p=0.016 and p=0.030, respectively) 
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Figure 2. ROC curve areas for C-reactive protein (2a) and procalcitonin (2b) to predict pyelonephritis 
DISCUSSION 
 Urinary tract infections are one of the most 
frequent infections of childhood, and can be 
diagnosed as pyelonephritis or cystitis. The 
differentiation between pyelonephritis and cystitis 
is important because of the long-term sequela of 
renal scarring that may occur following an episode 
of pyelonephritis
9
. Chronic renal disease or 
hypertension may be the consequence of renal 
scarring in future follow-up
10
.
 
 
 
 In order to distinguish the site of UTI, fever 
has usually been identified as the classic symptom 
of pyelonephritis; and the absence of 
feverindicates cystitis. However, some studies 
have shown that fever is not enough for the 
diagnosis of pyelonephritis, as a sole indicator
9,11
. 
Similar to these reports, fever was not a significant 
clinical sign of pyelonephritis in our study. In our 
cohort, fever was present in 78% of children with 
pyelonephritis and in 61% of children with cystitis. 
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We concluded that fever is not the diagnostic 
clinical criteria to distinguish pyelonephritis from 
cystitits.  
 The DMSA scan is the gold standard for the 
diagnosis of pyelonephritis. Besides, we included 
biomarkers such as CRP and PCT to determine 
the presence of pyelonephritis. In our study, 
median CRP level was significantly higher in 
children with pyelonephritis compared to those with 
cystitis. Although CRP had been reported as a 
significant biomarker of pyelonephritis in previous 
studies
9,11-15
 controversy about this data had also 
been revealed
16-18
. The median PCT level in our 
experience was also higher in children with 
pyelonephritis, as confirmed by other studies
12-15
. 
However, the significance of PCT as a predictor in 
pyelonephritis was not shown by several studies in 
children
17,18
. 
 The sensitivity and specificity of CRP in 
pyelonephritis has been reported between 64-
100% and 4-90%, respectively
11-21
. In the English 
literature, the lowest sensitivity to predict 
pyelonephritis for CRP was reported by Biggi et al. 
and the highest sensitivity was reported by 
Benador et al.
11,12
. In pyelonephritis, to predict the 
sensitivity of CRP in diagnosis, cut-off values of 2 
mg/dl, 5 mg/dl, and 10 mg/dl were associated with 
67%, 67%, and 73% sensitivity respectively, by 
Güven et al.
17
. In current study, a cut-off CRP 
value of 34 mg/L was found to be 69% sensitive to 
predict pyelonephritis, similar to the studies of both 
Biggi et al.
11
 (64% sensitivity) and Güven et al.
17
 
(67% sensitivity). Previously, the lowest specificity 
for CRP was detected by Ayazi et al.
16
 while the 
highest specificity was reported by Kotoula et al.
21
. 
Specificity of CRP was similar to the other studies 
of Biggi,
11
 Nikfar
15
 and Güven et al.
17
 (68%, 65% 
and 67% specificity, respectively) (Table 2). In 
some studies different cut-off values were given for 
CRP (Table 2). However, if the units used are 
standardised, such differences disappear. The 
most significantly different cut-off value was 87.5 
mg/dl, stated by Biggie et al.
11
. Although this study 
has similarities with ours in terms of population, 
age, and location, there are differences in the 
gender, race and number of the patients. The 
difference in the cut off value may be related to the 
differences in the race, gender and the number of 
the patients as well as the difference in the 
method. 
 Since 1993, PCT has been used to 
demonstrate the severity of infection in several 
studies in children; in a few studies, PCT and CRP 
levels have been compared as predictors of 
pyelonephritis. In previous studies, the lowest and 
highest sensitivities for PRC were reported as 58% 
and 100%
12-22
. The lowest sensitivity for PCT to 
predict pyelonephritis was reported by Gürgöze
13
 
while the highest sensitivity was reported by 
Bigot
19
. Sensitivity rates for PCT according to the 
different cut-off values of 0.5 ng/ml, 1 ng/ml, and 2 
ng/ml were declared  as 65%, 77%, and 100%, 
respectively by Güven et al
17
. In our study, at a 
cut-off value of 0.23 ng/ml, PCT was 69% sensitive 
to predict pyelonephritis. This result was similar to 
Tuerlinckx et al.[18] (68% sensitivity). In the 
previous studies, the lowest and highest 
specificities for PCT were 23% and 97%, 
respectively
21,18
. The lowest specificity was 
reported by Tuerlinckx
18
 at a cut-off value of 0.5 
ng/ml.
 
Different cut-off values of 0.5 ng/ml, 1 ng/ml, 
and 2 ng/ml for PCT were declared by Güven et 
al
17
 with 38%, 45%, and 43% specificity to predict 
pyelonephritis, respectively. Another report of low 
specificity for PCT was reported by Ayazi et al. as 
46%
6
 In our study, PCT showed higher specificity 
as 66%, similar with the study of Prat (62%).
23
. The 
highest specificity for PCT was reported by Kotoul 
et al.
21
. (Table 3). 
 It is very important to follow patients with the 
risk of renal scarring in UTIs with advanced 
screening methods. On the other hand, children 
with lower UTIs and with low risk of renal scarring 
shouldn't be exposed to unnecessary advanced 
screening methods. In deciding whether to use 
advanced screening methods or not, DMSA is still 
accepted as the gold standard, however, less 
invasive biochemical parameters with no radiation 
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exposition are still needed. In our study it has been 
proved that combined use of PCT and CRP is 
rather efficient in predicting pyelonephritis. In 
patients with high CRP and PCT values, 
pyelonephritis  has been proved to occur 5.8 times 
more. In addition to this, in case of patients with 
high PCT and CRP values, the ratio of 
pyelonephritis has been found as 83.3% (positive 
predictive value). Having the high specifity of 78% 
when using CRP and PCT together has been 
proved to be efficient in defining patients with low 
risk of renal scarring.  
CONCLUSION 
 We conclude that, CRP and PCT may be 
useful parameters to predict pyelonephritis when 
they are used in combination, and may help to 
determine whether DMSA scanning is necessary 
or not. Keeping in mind the possible disadvantages 
of DMSA scanning in children, this evaluation may 
be advantageous. 
REFERENCES  
1. American Academy of Pediatrics. Practice parameter: 
the diagnosis, treatment, and evaluation of the initial 
urinary tract infection in febrile infants and young 
children. Pediatrics. 1999;103:843-52. 
2. Ammenti A, Cataldi L, Chimenz R, et al. Febrile 
urinary tract infections in young children: 
recommendations for the diagnosis, treatment and 
follow-up. Acta-Paediatr. 2012;10:451-7. 
3. Glauser MP, Lyons JM, Braude AI. Prevention of 
chronic experimental pyelonephritis by suppression 
of acute suppuration. J Clin Invest. 1978;61:403-7. 
4. Bek K, Akman S, Bilge I, et al. Chronic kidney 
disease in children in Turkey. Pediatr Nephrol. 
2009;24:797-806. 
5. Jodal U, Lindberg U. Guidelines for management of 
children with urinary tract infection and vesico-
ureteral reflux. Recommendation from Swedish state 
of the art conference. Acta Paediatr. 1999;431:87-9. 
6. Rushton HG. The evaluation of acute pyhelonephritis 
and renal scarring with technetium 99m-
dimercaptosuccinic acid renal scintigraphy: evolving 
concepts and future directions. Pediatr Nephrol. 
1997;11:108-20. 
7. Pecile P, Mirion E, Romanello C, et al. Procalcitonin: 
A marker of severity of acute pyelonephritis among 
children. Pediatrics. 2004;114: 249-54. 
8. Assicot M, Gendrel D, Carsin H, et al. High serum 
procalcitonin concentrations in patients with sepsis 
and infection. Lancet. 1993;341:515-8. 
9. Garin EH, Olavarria F, Araya C, et al. Diagnostic 
significance of clinical and laboratory findings to 
localize site of urinary infection. Pediatr Nephrol. 
2007;22:1002-6. 
10. Jacobsson SH, Eklof O, Eriksson CG, et al. 
Development of hypertension and uremia after 
pyelonephritis in childhood:27 year follow-up. BMJ. 
1989;299:703-6. 
11. Biggi A, Dardanelli L, Pomero G, et al. Acute renal 
cortical scintigraphy in children with a first urinary 
tract infection. Pediatric Nephrol. 2001;16:733-8. 
12. Benador N, Siegrist CA, Gendrel D, et al. 
Procalcitonin is a marker of severity of renal lesions 
in pyelonephritis. Pediatrics. 1998;102:1422-5. 
13. Gürgöze MK, Akarsu S, Yılmaz E, et al. 
Proinflammatory cytokines and procalcitonin in 
children with acute pyelonephritis. Pediatr Nephrol. 
2005;20:1445-8. 
14. Smolkin V, Koren A, Raz R, et al. Procalcitonin as a 
marker of acute pyelonephritis in infants and children. 
Pediatr Nephrol. 2002;17:409-12. 
15. Nikfar R, Khotaee G, Ataee N, Shams S. Usefulness 
of procalcitonin rapid test for the diagnosis of acute 
pyelonephritis in children in the emergency 
department. Pediatr Int. 2010;52:196-8. 
16. Ayazi P, Mahyar A, Hashemi HJ, et al. Comparison 
of procalcitonin and C-reactive protein tests in 
children with urinary tract infection. Iran J Pediatr. 
2009;19:381-6. 
17. Güven AG, Kazdal HZ, Koyun M, et al. Accurate 
diagnosis of acute pyelonephritis: How helpful is 
procalcitonin? Nucl Med Commun. 2006;27:715-21. 
18. Tuerlinckx D, Borght TV, Glupczynski Y, et al. Is 
procalcitonin a good marker of renal lesion in febrile 
urinary tract infection? Eur J Pediatr. 2005;164:651-2. 
Kılıçaslan et al.       Cukurova Medical Journal  
 
 503 
19. Bigot S, Leblond P, Foucher C, et al. Usefulness of 
procalcitonin for the diagnosis of acute pyelonephritis 
in children. Arch Pediatr. 2005;12:1075-80. 
20. Karavanaki K, Haliotis FA, Sourani M, et al. DMSA 
scintigraphy in febrile urinary tract infections could be 
omitted in children with low procalcitonin levels. Infect 
Dis Clin Prac. 2007;15:377-81. 
21. Kotoula A, Gardikis S, Tsalkidis A, et al. 
Comparative efficacies of procalcitonin and 
conventional inflammatory markers for prediction of 
renal parenchymal inflammation in pediatric first 
urinary tract infection. Urology. 2009;73:782-6. 
22. Gervaix A, Galetto-Lacour A, Gueron T, et al. 
Usefulness of procalcitonin and C-reactive protein 
rapid tests for the management of children with 
urinary tract infection. Pediatr Infect Dis J. 
2001;20:507-11. 
23. Prat C, Dominguez J, Rodrigo C, et al. Elevated 
serum procalcitonin values correlate with renal 
scarring in children with urinary tract infection. Pediatr 
Infect Dis J. 2003;22:438-42. 
 
       Yazışma Adresi / Address for Correspondence: 
       Dr. Buket Kılıçaslan 
       Başkent University Faculty of Medicine  
       Adana Teahcing and Medical Research Center 
       Department of Pediatrics 
       ADANA 
       Tel: 0 532 313 72 02   
             +90 322 458 68 68 
       Fax: +90 322 459 26 22  
       E-mail: drbuketk73@yahoo.com 
 
       Geliş tarihi/Received on :  22.01.2015 
       Kabul tarihi/Accepted on: 20.02.2015 
 
 
 
